EDITORIAL

BTS guidelines for pneumonia

2004 update of BTS pneumonia guidelines: what’s new?

J T Macfarlane¹, D Boldy²

¹ Chairman of the BTS Pneumonia Guidelines Committee, Nottingham City Hospital, Nottingham NG5 1PB, UK
² Chairman of the BTS Standards of Care Committee, Pilgrim Hospital, Boston PE21 9QS, UK

Correspondence to:
Correspondence to:
Dr J T Macfarlane
Nottingham City Hospital Nottingham NG5 1PB, UK; jmacfar1@ncht.trent.nhs.uk

---

An update of the BTS guidelines for the management of community acquired pneumonia in adults

---

Keywords: community acquired pneumonia; adults; BTS guidelines

The first 150 words of the full text of this article appear below.

The BTS guidelines for the management of adult community acquired pneumonia (CAP), published in December 2001, assessed relevant evidence published up to 2000.¹ An update summarising more recent available evidence up to 2003 has just been published on the BTS website (www.brit-thoracic.org.uk/guidelines) using an identical search assessment and appraisal system. Minor additions or changes have been made in the sections on aetiology (related to nursing home acquired pneumonia), general investigations (use of C reactive protein and oximetry), general management, and vaccination strategies. The more important changes have been in the recommendations for the microbiological investigation of CAP, severity assessment, discharge planning, and antibiotics. At present these guidelines do not include information on severe acute respiratory syndrome (SARS), for which an updated specific guideline is available on the BTS website to help clinicians with case definition and management and will shortly be published in the . . . [Full text of this article]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Ho, P.-L., Cheng, V. C.-C., Chu, C.-M. (2009). Antibiotic Resistance in Community-Acquired Pneumonia Caused by Streptococcus pneumoniae, Methicillin-Resistant Staphylococcus aureus, and Acinetobacter baumannii. Chest 136: 1119-1127 [Abstract] [Full Text]  
• Bewick, T, Cooper, V J, Lim, W S (2009). Does early review by a respiratory physician lead to a shorter length of stay for patients with non-severe community-acquired pneumonia?. Thorax 64: 709-712 [Abstract] [Full Text]  
• Singanayagam, A., Chalmers, J.D., Hill, A.T. (2009). Severity assessment in community-acquired pneumonia: a review. QJM 102: 379-388 [Abstract] [Full Text]  
• Capelastegui, A, Espana, P P, Quintana, J M, Bilbao, A, Menendez, R, Zalacain, R, Torres, A (2009). Development of a prognostic index for 90-day mortality in patients discharged after admission to hospital for community-acquired pneumonia. Thorax 64: 496-501 [Abstract] [Full Text]  
• Lemyze, M, Salomon, S, Brown, D, Detouche, P, Collet, F (2009). What is the target?. BMJ 338: b1604-b1604 [Full Text]  
• Barker, B, Macfarlane, J, Lim, W S, Douglas, G, Macfarlane, J (2009). Local guidelines for management of adult community acquired pneumonia: a survey of UK hospitals. Thorax 64: 181-181 [Full Text]  
• Capelastegui, A., Espana, P. P., Bilbao, A., Martinez-Vazquez, M., Gorordo, I., Oribe, M., Urrutia, I., Quintana, J. M. (2008). Pneumonia: Criteria for Patient Instability on Hospital Discharge. Chest 134: 595-600 [Abstract] [Full Text]  
• Bont, J., Hak, E., Hoes, A. W., Macfarlane, J. T., Verheij, T. J. M. (2008). Predicting Death in Elderly Patients With Community-Acquired Pneumonia: A Prospective Validation Study Reevaluating the CRB-65 Severity Assessment Tool. Arch Intern Med 168: 1465-1468 [Full Text]  
• Durrington, H. J, Summers, C. (2008). Recent changes in the management of community acquired pneumonia in adults. BMJ 336: 1429-1433 [Full Text]  
• Bont, J., Hak, E., Hoes, A. W., Schipper, M., Schellevis, F. G., Verheij, T. J. M. (2007). A prediction rule for elderly primary-care patients with lower respiratory tract infections. Eur Respir J 29: 969-975 [Abstract] [Full Text]  
• Yan Man, S., Lee, N., Ip, M., Antonio, G. E, Chau, S. S L, Mak, P., Graham, C. A, Zhang, M., Lui, G., Chan, P. K S, Ahuja, A. T, Hui, D. S, Sung, J. J Y, Rainer, T. H (2007). Prospective comparison of three predictive rules for assessing severity of community-acquired pneumonia in Hong Kong. Thorax 62: 348-353 [Abstract] [Full Text]  
• Espana, P. P., Capelastegui, A., Gorordo, I., Esteban, C., Oribe, M., Ortega, M., Bilbao, A., Quintana, J. M. (2006). Development and Validation of a Clinical Prediction Rule for Severe Community-acquired Pneumonia. Am. J. Respir. Crit. Care Med. 174: 1249-1256 [Abstract] [Full Text]  
• Briones, M. L., Blanquer, J., Ferrando, D., Blasco, M. L., Gimeno, C., Marin, J. (2006). Assessment of Analysis of Urinary Pneumococcal Antigen by Immunochromatography for Etiologic Diagnosis of Community-Acquired Pneumonia in Adults. CVI 13: 1092-1097 [Abstract] [Full Text]  
• Saravanan, V., Kelly, C. (2006). Drug-related pulmonary problems in patients with rheumatoid arthritis. Rheumatology (Oxford) 45: 787-789 [Full Text]  
• Hoare, Z., Lim, W. S. (2006). Pneumonia: update on diagnosis and management.. BMJ 332: 1077-1079 [Full Text]  
• Buising, K L, Thursky, K A, Black, J F, MacGregor, L, Street, A C, Kennedy, M P, Brown, G V (2006). A prospective comparison of severity scores for identifying patients with severe community acquired pneumonia: reconsidering what is meant by severe pneumonia. Thorax 61: 419-424 [Abstract] [Full Text]  
• Lim, W-S (2004). Identifying failure of empirical treatment for pneumonia: vigilance and common sense. Thorax 59: 918-919 [Full Text]  
• (2004). {blacktriangledown}Moxifloxacin - a new fluoroquinolone antibacterial. DTB 42: 61-62 [Abstract] [Full Text]